17
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of the clinical cutoff level of serum (1 → 3)-β-d-glucan in patients with connective tissue diseases complicated by deep fungal infections

, , , &
Pages 366-369 | Received 17 Nov 2009, Accepted 17 Feb 2010, Published online: 02 Jan 2014

References

  • Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161–89.
  • Kato K, Yoshida S, Fukaya S, Yoshida H, Mizutani A, Katayama M, et al. A study of infectious diseases in patients with connective tissue diseases. J Japanese Assoc Infect Dis. 2003;77:185.
  • Mori T, Ikemoto H, Matsumura M, Yoshida M, Inada K, Endo S, et al. Evaluation of plasma (1 - 3)-/3-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem. 1997;35:553–60.
  • Miyazaki T, Kohno S, Koga H, Kaku M, Mitsutake K, Maesaki S, et al. G test, a new direct method for diagnosis of Candida infection: comparison with assays for beta-glucan and mannnan antigen in a rabbit model of systemic candidiasis. J Clin Lab Anal. 1992;6:315–8.
  • Tamura H, Arimoto Y, Tanaka S, Yoshida M, Obayashi T, Kawai T. Automated kinetic assay for endotoxin and (1 - 3)-J3-D-glucan in human blood. Clin Chim Acta. 1994;226:109–12.
  • Obayashi T, Yoshida M, Tamura H, Aketagawa J, Tanaka S, Kawai T, et al. Determination of plasma (1 - 3)-/3-D-glican: a new diagnostic aid to deep mycosis. J Med Vet Mycol. 1992;30:275–80.
  • Pauw B, Walsh T, Donnely JP, Ascioglu S, Bennett J, Bille J, et al. EORTC/BAMSG consensus revised definitions, draft VI. http://www.doctorfungus.org/lecture/EORTC_MSG_rev06.htm.
  • Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985;157:611–4.
  • Logan PM, Primack SL, Miller RR, Milner NL. Invasive asper-gillosis of the airways; radiographic, CT and pathologic findings. Radiology. 1994;19:383–8.
  • Ascioglu S, Rex JH, Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international concensus. Clin Infect Dis. 2002;34:7–14.
  • Obayashi T, Yoshida M, Mori T, Tamura H, Aketagawa J, Tanaka S, et al. Plasma (1 - 3)-/3-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile epsodes. Lancet. 1995;345:17–20.
  • Tanaka H, Goto H, Sakaki S, Yoshinari S, Yoshizawa M, Shimazaki S, et al. Efficacy study of early presumptive therapy (EPT) for deep fungal infection. Nippon Ishinkin Gakkai Zasshi. 2004;45:203–8.
  • Imai K, Ashitani J, Imazu Y, Yanagi S, Sano S, Tokojima M, et al. Farmer's lung cases of a farmer and his son with high BAL fluid beta-D-glucan levels. Nihon Kokyuki Gakkai Zasshi. 2004;42:1024–9.
  • Hayashi M, Oku S, Mizobuchi S, Takeuchi M, Goto K, Matsumi M, et al. A case of fungal sepsis with high serum (1 - 3)-/3-D-glucan level. Nihon Shuchu Chiryo Igakukai Zasshi. 2003;10:187–91.
  • Moro H, Tsukada H, Ohara T, Susa R, Tanabe Y, Suzuki E. Clinical evaluation of performance of a new diagnostic method for deep mycosis by measuring /3-glucan concentration in the blood. Kansenshogaku Zasshi. 2003;77:219–26.
  • Solomkin JS, Flohr A, Simmons RL. Indications for therapy fungemia in postoperative patients. Arch Surg. 1982;117:1272–5.
  • Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149:2349–53.
  • Dube MP, Heseeltine PNR, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rug-osa in a burn unit. Clin Infect Dis. 1994;18:77–82.
  • Halliday C, Wu QX, James G, Sorrell T. Development of a nested qualitative real-time per assay to detect Aspergillus species DNA in clinical specimens. J Clin Microbiol. 2005;43:5366–8.
  • Singh G, Imai J, Clemons KV, Stevens DA. Efficacy of caspo-fungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methods. Antimicrob Agents Chemother. 2005;49:1369–76.
  • de Aguirre L, Hurst SF, Choi JS, Shin JH, Hinrikson HP, et al. Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay. J Clin Microbiol. 2004;42:3495–504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.